The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDci Advisors Regulatory News (DCI)

Share Price Information for Dci Advisors (DCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.75
Bid: 4.50
Ask: 5.00
Change: 0.09 (1.89%)
Spread: 0.50 (11.111%)
Open: 4.75
High: 4.86
Low: 4.75
Prev. Close: 4.75
DCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

13 Feb 2023 07:00

RNS Number : 6287P
Dolphin Capital Investors Limited
13 February 2023
 

Dolphin Capital Investors Limited

("Dolphin" or the "Company")

Director changes

 

Dolphin, an investor in high-end resort developments in the eastern Mediterranean, announces that Martin Adams, who has been Chairman of the Board of Directors of the Company since 30 June 2021, has resigned as a Director with immediate effect.

 

The Board and the Investment Manager would like to thank Martin for his guidance and support in (i) improving the Company's corporate governance; and (ii) implementing its new investing policy and realisation strategy aimed at selling the remaining investments, repaying debt and distributing the net proceeds to Shareholders.

Sean Hurst has been appointed as a Director, also with immediate effect, and elected by the Board to be the new Chairman. He has 32 years experience in the financial services industry including 29 years involved in listed closed-end investment companies and 15 years as an investment manager focused on absolute return, relative value mandates investing in closed end funds. He was a co-founder, Director and CIO of Albion Asset Management, a French regulated asset management company, from 2005-2009. He is an experienced multi-jurisdictional Director including roles at London/AIM-listed funds and numerous offshore and UCITS funds and is a specialist in UK-listed fund reorganisations. He is currently the Non-Executive Chairman of JPEL Private Equity Ltd which is invested in Global private equity funds and co-investments and the Senior Independent Director of Vietnam Holding Ltd which is invested in Vietnam equities and he was a Non-Executive Director of AIM-listed ARC Capital Holdings Ltd which was invested in Chinese private equity. He holds an MBA in Finance from CASS Business School in London and is a resident of France.

Enquiries

 Dolphin Capital Investors

Nicolai Huls, Chair, Nomination and Corporate Governance Committee

Via FIM Capital Limited

 

Dolphin Capital Partners

Miltos E Kambourides

miltos@dolphincp.com

 

 

 

finnCap (Nominated Adviser & Broker)

William Marle / Jonny Franklin-Adams / Edward Whiley / Milesh Hindocha (Corporate Finance)

Mark Whitfeld / Pauline Tribe (Sales)

 

 

+44 (0) 20 7220 0500

 

 

FIM Capital Limited (Administrator)

Lesley Lennon / Grainne Devlin (Corporate Governance)

llennon@fim.co.im / gdevlin@fim.co.im

 

 

INFORMATION REQUIRED UNDER RULE 17 AND SCHEDULE 2, PARAGRAPH (G) OF THE AIM RULES FOR COMPANIES ("AIM RULES")

Full name:

Sean Leslie Hurst

Age:

58

DCI shares held:

None

Current directorships:

Albion Consulting SARL

Carillon Capital Ltd

CIAM Fund SA

JPEL Private Equity Limited

Vietnam Holding Limited

 

Historic directorships in previous 5 years:

 

Impact Investment Trust Plc

Satellite Event-Driven UCITS Fund SICAV

 

 

 

There is no further information to be disclosed in relation to the appointment pursuant to Rule 17 and Schedule 2, paragraph (g) of the AIM Rules.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGMZKGFGFZM
Date   Source Headline
16th Apr 202412:38 pmRNSShareholder Loan & Related Party Transaction
15th Apr 20242:26 pmRNSShareholder Update
2nd Apr 20243:33 pmRNSUpdate on legal actions
28th Mar 20249:43 amRNSLegal Update
14th Mar 20242:57 pmRNSFurther Shareholder Loan and RPT
27th Feb 20242:17 pmRNSHolding(s) in Company
23rd Feb 20245:00 pmRNSHolding(s) in Company
9th Feb 20245:07 pmRNSFurther Shareholder Loan
9th Feb 20243:39 pmRNSHolding(s) in Company
27th Dec 20232:23 pmRNSGovernment Grant to the Kilada Project
15th Dec 20239:36 amRNSResult of AGM
13th Dec 20238:53 amRNSShareholder Loan
13th Dec 20238:46 amRNSUpdate on legal actions
1st Dec 20233:44 pmRNSHolding(s) in Company
22nd Nov 202312:32 pmRNSAGM Timing
21st Nov 202311:30 amRNSNotice of AGM
16th Nov 20233:31 pmRNSShareholder Loan
6th Oct 20232:17 pmRNSShareholder Loan
29th Sep 20237:00 amRNSHalf-year Report
14th Sep 202312:32 pmRNSShareholder Loans and a Related Party Transaction
7th Sep 20234:17 pmRNSHolding(s) in Company
30th Aug 202310:22 amRNSDirector/PDMR Shareholding
29th Aug 202310:07 amRNSDirector/PDMR Shareholding
21st Aug 202311:46 amRNSHolding(s) in Company
8th Aug 20239:23 amRNSDirector/PDMR Shareholding
3rd Aug 20234:35 pmRNSDirector/PDMR Shareholding
1st Aug 20234:33 pmRNSNotification of Transaction of a PCA
27th Jul 20233:14 pmRNSDirector/PDMR Shareholding
30th Jun 20231:25 pmRNSAnnual Financial Report
29th Jun 20234:50 pmRNSShareholder Loans
7th Jun 20237:00 amRNSChange of Name
26th May 20232:19 pmRNSShareholder Loans
26th May 20239:41 amRNSKilada Funding
3rd May 20234:24 pmRNSHolding(s) in Company
28th Apr 20239:41 amRNSShareholder Loans
27th Apr 20232:45 pmRNSHolding(s) in Company
19th Apr 20237:00 amRNSShareholder Loans and Related Party Transaction
18th Apr 202310:30 amRNSShareholder Update
13th Apr 20234:21 pmRNSHolding(s) in Company
13th Apr 20233:58 pmRNSHolding(s) in Company
11th Apr 20234:36 pmRNSHolding(s) in Company
11th Apr 20233:12 pmRNSFiling of Claim Form
6th Apr 20234:50 pmRNSHolding(s) in Company
5th Apr 20234:39 pmRNSNew website now live
31st Mar 20236:13 pmRNSCompany Website
20th Mar 20237:00 amRNSTermination of Inv. Manager & Removal of Director
17th Feb 20233:48 pmRNSHolding(s) in Company
13th Feb 20237:00 amRNSDirectorate Change
23rd Dec 20229:07 amRNSCompletion of disposal of interest in OOKI
31st Oct 202210:24 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.